Cancer cachexia market

More than half of the cancer patients suffer from Cachexia, and over 30% of the cancer patients succumb to death due to complications that arise from cachexia.

However, advanced medical technologies and emerging therapies have led to an increase in the diagnosis and treatment of cancer cachexia.

Several pharma companies including Tetra Bio-Pharma ,Helsinn Group/Ono Pharmaceutical, AEterna Zentaris Inc., ACTIMED THERAPEUTICS, PsiOxus Therapeutics, Pfizer, XBiotech USA, Inc., Cannabics Pharmaceuticals Inc., NGM Biopharmaceuticals, Artelo Biosciences, Inc. and many more are advancing cancer cachexia pipeline to address the unmet needs in the Cancer cachexia market.

Visit to read more: https://www.delveinsight.com/blog/cancer-cachexia-pipeline-therapies/